Gerald E Quirk - Net Worth and Insider Trading

Gerald E Quirk Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gerald E Quirk owns 3 companies in total, including Syros Pharmaceuticals Inc (SYRS) , Eledon Pharmaceuticals Inc (ELDN) , and Infinity Pharmaceuticals Inc (INFIQ) .

Click here to see the complete history of Gerald E Quirk’s form 4 insider trades.

Insider Ownership Summary of Gerald E Quirk

Ticker Comapny Transaction Date Type of Owner
SYRS Syros Pharmaceuticals Inc 2016-09-26 Chief Legal Officer
ELDN Eledon Pharmaceuticals Inc 2015-05-26 General Counsel & Executive VP
INFIQ Infinity Pharmaceuticals Inc 2010-01-01 VP,Cor. Affairs & Gnrl Counsel

Gerald E Quirk Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gerald E Quirk Ownership Network

Ownership Network List of Gerald E Quirk

No Data

Ownership Network Relation of Gerald E Quirk

Insider Network Chart

Gerald E Quirk Owned Company Details

What does Syros Pharmaceuticals Inc do?

Who are the key executives at Syros Pharmaceuticals Inc?

Gerald E Quirk is the Chief Legal Officer of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include Chief Financial Officer Jason Haas , Chief Commercial Officer Chee Conley , and Chief Medical Officer David Roth .

Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary

Over the past 18 months, Gerald E Quirk made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net purchase of 100,000 shares made by Chee Conley .

In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 200,000 shares, with a net purchase of 200,000 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 1,073,765 shares.

Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Syros Pharmaceuticals Inc Insider Transactions

No Available Data

Gerald E Quirk Mailing Address

Above is the net worth, insider trading, and ownership report for Gerald E Quirk. You might contact Gerald E Quirk via mailing address: C/o Syros Pharmaceuticals, Inc., 620 Memorial Drive, Cambridge Ma 02139.